IRIS
GABANO, Elisabetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.812
EU - Europa 5.255
AS - Asia 3.196
SA - Sud America 554
Continente sconosciuto - Info sul continente non disponibili 191
AF - Africa 113
OC - Oceania 2
Totale 15.123
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.621
RU - Federazione Russa 1.373
IE - Irlanda 1.084
SG - Singapore 942
CN - Cina 870
DE - Germania 698
SE - Svezia 551
HK - Hong Kong 463
VN - Vietnam 433
BR - Brasile 427
UA - Ucraina 418
IT - Italia 374
FI - Finlandia 261
FR - Francia 212
IN - India 156
GB - Regno Unito 118
CA - Canada 114
BD - Bangladesh 64
AR - Argentina 46
MX - Messico 45
PL - Polonia 37
IR - Iran 36
KR - Corea 36
ID - Indonesia 35
ZA - Sudafrica 33
BJ - Benin 30
TR - Turchia 29
JP - Giappone 28
ES - Italia 25
BE - Belgio 24
EC - Ecuador 20
IQ - Iraq 18
AT - Austria 15
CO - Colombia 15
LT - Lituania 15
NL - Olanda 15
PK - Pakistan 15
CL - Cile 14
EG - Egitto 12
UZ - Uzbekistan 11
VE - Venezuela 11
PY - Paraguay 10
MA - Marocco 9
TN - Tunisia 9
EU - Europa 8
PH - Filippine 8
RO - Romania 8
SA - Arabia Saudita 7
AL - Albania 6
JM - Giamaica 6
CR - Costa Rica 5
JO - Giordania 5
PE - Perù 5
TH - Thailandia 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CH - Svizzera 4
HN - Honduras 4
HR - Croazia 4
IL - Israele 4
PA - Panama 4
BG - Bulgaria 3
ET - Etiopia 3
GT - Guatemala 3
KE - Kenya 3
MY - Malesia 3
NG - Nigeria 3
NP - Nepal 3
SV - El Salvador 3
AU - Australia 2
CG - Congo 2
CI - Costa d'Avorio 2
DZ - Algeria 2
HU - Ungheria 2
LB - Libano 2
PS - Palestinian Territory 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BZ - Belize 1
CM - Camerun 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LY - Libia 1
ML - Mali 1
Totale 14.935
Salva come PNG Salva come JPEG
Città #
Dublin 1.076
Jacksonville 752
San Jose 478
Hong Kong 460
Dearborn 412
Singapore 373
Ashburn 365
Council Bluffs 298
Beijing 272
New York 256
Chandler 217
Wilmington 186
Moscow 165
Los Angeles 152
Ho Chi Minh City 149
Ann Arbor 147
Lauterbourg 141
Lawrence 134
Princeton 134
Columbus 121
Piemonte 104
Hanoi 95
San Mateo 90
Andover 84
Munich 83
Buffalo 75
Santa Clara 71
Toronto 59
São Paulo 57
Bremen 50
Grafing 49
Orem 48
Novara 40
Dallas 38
Seoul 34
Frankfurt am Main 33
Redondo Beach 32
Cotonou 30
Helsinki 28
Denver 27
Houston 27
Chicago 26
Atlanta 25
Brooklyn 25
Tokyo 25
Warsaw 25
Chennai 24
Stockholm 23
Guangzhou 22
Haiphong 22
Mexico City 22
Montreal 22
Leawood 21
London 21
Nanjing 21
Brussels 20
Hefei 20
Cave Creek 19
Monmouth Junction 18
Tianjin 18
Woodbridge 18
Zanjan 18
Boardman 17
Manchester 17
Da Nang 16
Hangzhou 16
Johannesburg 16
Phoenix 16
Kunming 15
Norwalk 15
Poplar 15
Rio de Janeiro 15
Biên Hòa 14
Milan 14
Mumbai 14
Nuremberg 14
Shanghai 13
Augusta 12
Seattle 12
Turin 12
Kocaeli 11
Curitiba 10
Jinan 10
Tashkent 10
Turku 10
Ankara 9
Ardabil 9
Bexley 9
Boston 9
Fairfield 9
Hải Dương 9
Jakarta 9
Ninh Bình 9
Rome 9
San Francisco 9
Amsterdam 8
Hebei 8
Lahore 8
Miami 8
Quito 8
Totale 8.341
Salva come PNG Salva come JPEG
Nome #
Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen 169
Cisplatin and valproate released from the bifunctional [Pt(IV)Cl2(NH3)2(valproato)2] antitumor prodrug or from liposome formulations: who does what? 161
Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells 154
A view on multi-action Pt(IV) antitumor prodrugs 154
Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs 152
195Pt NMR chemical shift: a chemometric approach 149
Transition metal carbonyl clusters in biology: A futile or niche research area? 147
Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure-activity relationship modeling 146
The cisplatin-based Pt(IV)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions 144
Assessment of the anticancer potentiality of a new platinum nanoparticulate coniugate 142
Beyond the Pt(II)-based chemotherapy: Pt(IV) complexes as oral anticancer pro-drugs 142
A different way for the oxidation of the Pt(II) complexes 141
Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer 141
A multi-methodological inquiry of the behavior of cisplatin-based Pt(IV) derivatives in the presence of bioreductants with a focus on the isolated encounter complexes 141
Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug 140
Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 139
Cis,cis,trans-[PtIVCl2(NH3)2(perillato)2], a dual-action prodrug with excellent cytotoxic and antimetastatic activity 139
Antiproliferative Activity of PtII Complexes with Carboxylated Phosphanes in Chelated or Ring-Opened Forms 138
The antiproliferative activity of dicobalt-hexacarbonyl-aspirin complex on different malignant pleural mesotelioma phenotypes 136
Different strategies to exploit Pt(IV) complexes as pro-drugs 135
A step towards development of promising trypanocidal agents: Synthesis, characterization and in vitro biological evaluation of ferrocenyl Mannich base-type derivatives 135
Functionalized nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 134
Antitumor platinum(IV) pro-drugs: synthesis, characterization, cytotoxicity and QSAR analysis 133
A New Entry to Asymmetric Platinum(IV) Complexes via Oxidative Chlorination 133
Host-guest inclusion systems of Pt(IV)-bis(benzoato) anticancer drug candidates and cyclodextrins 133
How to obtain Pt(IV) complexes suitable for conjugation to nanovectors from the oxidation of [PtCl(terpyridine)]+ 133
Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs 132
Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: How long the organic chain should be? 131
Moving the paradigm in platinum-based chemotherapy from Pt(II) to Pt(IV) complexes? 129
Study of the synthesis, antiproliferative properties, and interaction with DNA and polynucleotides of cisplatin-like Pt(II) complexes containing carcinogenic polyaromatic amines 129
May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs? 128
Application of microwave-assisted heating to the synthesis of Pt(II) complexes 128
HPLC method for the determination of monomer conversion and composition during the poly(styrene-r-methylmethacrylate) polymerization 128
Cytotoxicity of some Pt(II)-diamine complexes: a QSAR evaluation of the effect of chelating arms and leaving groups 125
Estradiol as Carrier For Selective Delivery of Cytotoxic Pt(II) Complexes to Cancer Cell Nuclei 124
Experimental (RP-HPLC) and theoretical (MIFs) study of the lipophilicity of a series of Pt(IV) complexes 124
An unsymmetric cisplatin-based Pt(IV) derivative containing 2-(2-propynyl)octanoate: A very efficient multi-action antitumor prodrug candidate 122
Experimental and molecular modeling approaches to determine the lipophilicity of a Pt(IV) pro-drugs 119
Application of the anthraquinone drug rhein as an axial ligand in bifunctional Pt(iv) complexes to obtain antiproliferative agents against human glioblastoma cells 118
Bifunctional Pt-ethacrynic acid conjugates for malignant mesothelioma 117
Effects of dimethylsulfoxide and ethanol on the cytotoxic activity of titanocene dichloride 117
Polyanionic Biopolymers for the Delivery of Pt(II) Cationic Antiproliferative Complexes 117
Pt-195 NMR spectroscopy: A chemometric approach 116
Evaluation of Platinum–Ethacrynic Acid Conjugates in the Treatment of Mesothelioma 115
Freshening up Old Methods for New Students: A Colorful Laboratory Experiment to Measure the Formation Constants of Ni(II) Complexes Containing Ethane-1,2-Diamine 115
Anthracene-terpyridine metal complexes as new G-quadruplex DNA binders 114
Synthesis of PtIV-Biomolecule Conjugates through Click Chemistry 114
Synthesis, characterization and antiproliferative activity of platinum(IV) derivates of picoplatin 113
Pros and cons of bifunctional platinum drugs: two are (not always) better than one 113
Synthesis and characterization of cyclohexane-1R,2R-diamine-based Pt(iv) dicarboxylato anticancer prodrugs: their selective activity against human colon cancer cell lines 113
Classical Pt(II) anticancer complexes revised in view of drug targeting and delivery 112
Two are (not always) better than one: the case of bifunctional platinum(IV) drugs 112
Solvolysis of a Series of Cisplatin-Like Complexes – Comparison between DNA-Biosensor and Conductivity Data 111
Cellular uptake of antitumor platinum(II)-complexes evaluated by means of ICP-MS technique 110
Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin 110
The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells 110
Pt(iv) complexes based on cyclohexanediamines and the histone deacetylase inhibitor 2-(2-propynyl)octanoic acid: synthesis, characterization, cell penetration properties and antitumor activity 110
Pt(IV) – histone deacetylase inhibitor conjugates for citotoxicity studies on MPM cells 109
Assessment of the in vivo antiproliferative activity of a novel platinum nanoparticulate pharmacophore 108
Molecular Interaction Fields vs. Quantum-Mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes 108
Prediction of logP for Pt(II) and Pt(IV) complexes: Comparison of statistical and quantum-chemistry based approaches 106
Bioinorganic chemistry: the study of the fate of platinum-based antitumour drugs 105
A comparative study of the effects of platinum(II) complexes on β-amyloid aggregation: Potential neurodrug applications 105
Cytotoxicity of cis-platinum(II) conjugate models. The effect of chelating arms and leaving groups on cytotoxicity: A quantitative structure-activity relationship approach 104
Revisiting [PtCl2(cis-1,4-DACH)]: An Underestimated Antitumor Drug with Potential Application to the Treatment of Oxaliplatin-Refractory Colorectal Cancer 104
Pt(IV) complexes as anticancer prodrugs 104
Can the Self-Assembling of Dicarboxylate Pt(IV) Prodrugs Influence Their Cell Uptake? 103
Assessment of the in vivo antiproliferative activity of a novel particulate pharmacophore 102
Metallo-drugs in the Treatment of Malignant Pleural Mesothelioma 102
Unprecedented one-pot synthesis of an unsymmetrical cisplatin-based Pt(IV)-acetamidato complex 102
Unsymmetric cisplatin-based pt(Iv) conjugates containing a parp-1 inhibitor pharmacophore tested on malignant pleural mesothelioma cell lines 102
Pt(IV)/Re(I) Chitosan Conjugates as a Flexible Platform for the Transport of Therapeutic and/or Diagnostic Anticancer Agents 101
trans,cis,cis-Bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a Prodrug Candidate for the Treatment of Oxaliplatin-Refractory Colorectal Cancer 100
Pyrazolyl-diamine Pt(II) complexes bearing DNA-intercalating moieties: Synthesis, characterization and in vitro evaluation 99
Bifunctional Ethacrynic Acid – Pt Conjugates: In vitro Treatment of Malignant Pleural Mesothelioma 98
Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes 98
Electrochemical Biosensor Assay of the Interaction between [PtCl(n)(NH(3))(4-n)]((2-n)) (n=0-4) Complexes and ds-DNA 98
Solvolysis of Cisplatin and N-Methylated cis-[PtCl2(en)] Complexes – Comparison between DNA-Biosensor and Conductivity Data 97
Conjugation between maleimide-containing Pt(IV) prodrugs and furan or furan-containing drug delivery vectors via Diels-Alder cycloaddition 95
Bidentate and tridentate pyrazolyl-containing Pt(II) complexes: synthesis, characterization and in vitro evaluation 93
Pt(II) complexes with bidentate and tridentate pyrazolyl-containing chelators: synthesis, structural characterization and biological studies 93
Can an Elusive Platinum(III) Oxidation State be Exposed in an Isolated Complex? 93
Studies on Log Po/w of Quinoxaline di-N-Oxides: A Comparison of RP-HPLC Experimental and Predictive Approaches 91
Targeting and delivery of Pt(II) antiproliferative drugs 89
Synthesis and characterisation of estrogenic carriers for cytotoxic Pt(II) fragments: biological activity of the resulting complexes 89
Experimental determination and modeling of the lipophilicity in platinum complexes 88
Estrogenic carriers for cytotoxic Pt(II) complexes: light and shade 85
Pt(iv) antitumor prodrugs: dogmas, paradigms, and realities 85
Nano-vectors for targeting and delivery of Pt-based anti-tumor drugs 84
Uptake of antitumor platinum(II)-complexes by cancer cells, assayed by inductively coupled plasma mass spectrometry (ICP-MS) 84
Functionalized thymidine derivatives as carriers for the γ-emitter technetium tricarbonyl moiety 84
Ethynylestradiol-Pt(II) complexes for selective drug targeting 83
The Relevance of Polar Surface Area (PSA) in Rationalizing Biological Properties of Several cis-Diamminemalonatoplatinum(II)-derivatives 83
Elusive Intermediates in the Breakdown Reactivity Patterns of Prodrug Platinum(IV) Complexes 83
Online OCHEM multi-task model for solubility and lipophilicity prediction of platinum complexes 82
Biological Activity of Enantiomeric Complexes [PtCl2L2] (L2 = Aromatic Bisphosphanes and Aromatic Diamines) 82
Poly(methylmetacrylate) (PMMA) core-shell nanospheres act as efficient pharmacophores for the antiproliferative [PtCl3(NH3)]- complex by forming ionic couples 82
Rhein to impart antimetastatic features to Pt(IV) complexes and to target brain 81
Pros and cons of bifunctional platinum(iv) antitumor prodrugs: two are (not always) better than one 81
Ethynylestradiol Derivatives as Carrier for Selective Vehiculation of Cytotoxic Pt(II)-Malonate and Radioactive Tc Fragments Towards Cancer Cells 79
Totale 11.431
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.499
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.499
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022915 0 17 110 114 42 0 138 27 64 23 174 206
2022/20232.176 148 89 159 48 133 204 45 125 1.085 35 69 36
2023/2024676 48 59 57 11 103 0 130 8 9 4 146 101
2024/20251.397 16 49 88 25 70 94 158 82 312 156 73 274
2025/20266.086 338 276 470 941 553 420 793 1.006 426 395 299 169
2026/2027611 256 355 0 0 0 0 0 0 0 0 0 0
Totale 15.123